Patents by Inventor Dongzhou Liu

Dongzhou Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240325549
    Abstract: The present invention relates to long-acting GLP-1/GIP dual agonist compounds having a dual agonistic effect on glucagon-like peptide-1 (GLP-1) receptor and human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to the use of said compounds in the manufacture of medicaments for treating Type II diabetes mellitus.
    Type: Application
    Filed: March 12, 2024
    Publication date: October 3, 2024
    Inventors: Nan ZHANG, Chunhua Jiang, Dongzhou Liu, Li Teng, Jiale Shen
  • Publication number: 20240208952
    Abstract: Provided are a series of thiophene GLP-I receptor agonist com-pounds, a preparation method therefor and the pharmaceutical use thereof. The compounds can be used for preparing drugs for treating or preventing GLP-1-mediated diseases and related diseases.
    Type: Application
    Filed: March 17, 2022
    Publication date: June 27, 2024
    Inventors: Wenqiang ZHAI, Zhimin ZHANG, Liubin GUO, Dongzhou LIU, Hao PAN
  • Publication number: 20140065213
    Abstract: The present invention is directed to twice daily sustained release pharmaceutical composition of paracetamol having an immediate release phase of paracetamol and a sustained release phase of paracetamol, said composition having unique and advantageous pharmacokinetic properties and a pharmaceutical composition comprising only a sustained release phase of paracetamol having unique and advantageous pharmacokinetic properties.
    Type: Application
    Filed: May 4, 2012
    Publication date: March 6, 2014
    Applicant: GlaxoSmithKline, LLC
    Inventors: Carla Valenti Buan, Dongzhou Liu, Kanji Meghpara